<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Targeted therapy of lung cancer - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.25wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Targeted_therapy_of_lung_cancer" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;action=edit" />
<link rel="apple-touch-icon" href="//bits.wikimedia.org/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="//bits.wikimedia.org/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Targeted_therapy_of_lung_cancer" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="http://en.wikipedia.org/wiki/Targeted_therapy_of_lung_cancer" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=ext.gadget.DRN-wizard%2CReferenceTooltips%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.rtlcite%2Cwikihiero%2CwikimediaBadges%7Cext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init%2Cnolanglinks&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: enwiki:resourceloader:filter:minify-css:7:3904d24a08aa08f6a68dc338f9be277e */</style>
<script src="//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Targeted_therapy_of_lung_cancer","wgTitle":"Targeted therapy of lung cancer","wgCurRevisionId":610049923,"wgRevisionId":610049923,"wgArticleId":26670758,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["All articles lacking reliable references","Articles lacking reliable references from December 2012","All articles with unsourced statements","Articles with unsourced statements from December 2012","Articles with unsourced statements from December 2010","Pages that use a Medicine navs subtemplate","Lung cancer","Cancer treatments"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Targeted_therapy_of_lung_cancer","wgRelevantArticleId":26670758,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgVisualEditor":{"isPageWatched":false,"pageLanguageCode":"en","pageLanguageDir":"ltr","svgMaxSize":4096,"namespacesWithSubpages":{"6":0,"8":0,"1":true,"2":true,"3":true,"4":true,"5":true,"7":true,"9":true,"10":true,"11":true,"12":true,"13":true,"14":true,"15":true,"100":true,"101":true,"102":true,"103":true,"104":true,"105":true,"106":true,"107":true,"108":true,"109":true,"110":true,"111":true,"830":true,"831":true,"447":true,"2600":false,"828":true,"829":true}},"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgULSAcceptLanguageList":["en-us","en","ja","zh-cn","zh"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q7685917"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});},{},{},{});mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});},{},{},{});
/* cache key: enwiki:resourceloader:filter:minify-js:7:94007ea073e20ad4a3cdce36b2f2e369 */
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static-1.25wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Targeted_therapy_of_lung_cancer skin-vector action-view vector-animateLayout">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en"><span dir="auto">Targeted therapy of lung cancer</span></h1>
						<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><p><b>Targeted therapy of lung cancer</b> refers to using agents specifically designed to selectively target molecular pathways responsible for, or that substantially drive, the <a href="/wiki/Malignant" title="Malignant" class="mw-redirect">malignant</a> <a href="/wiki/Phenotype" title="Phenotype">phenotype</a> of <a href="/wiki/Lung_cancer" title="Lung cancer">lung cancer</a> <a href="/wiki/Cell_(biology)" title="Cell (biology)">cells</a>, and as a consequence of this (relative) selectivity, cause fewer <a href="/wiki/Toxic" title="Toxic" class="mw-redirect">toxic</a> effects on normal cells.</p>
<p>Most previous <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> drugs for cancer were (relatively) nonselective in their activity. Although their exact mechanisms of action were varied and complex, they generally worked by damaging cells undergoing <a href="/wiki/Mitosis" title="Mitosis">mitosis</a>, which is usually more common in malignant tumors than in most normal tissues. Targeted agents are designed to be selective in their effects by modulating the activity of <a href="/wiki/Proteins" title="Proteins" class="mw-redirect">proteins</a> necessary and essential for <a href="/wiki/Oncogenesis" title="Oncogenesis" class="mw-redirect">oncogenesis</a> and maintenance of cancer, particularly <a href="/wiki/Enzymes" title="Enzymes" class="mw-redirect">enzymes</a> driving the uncontrolled growth, angiogenesis, invasiveness, and <a href="/wiki/Metastasis" title="Metastasis">metastasis</a> characteristic of malignant tumors. The increased differential activity usually results in fewer troubling <a href="/wiki/Side_effects" title="Side effects" class="mw-redirect">side effects</a> for cancer patients, particularly less <a href="/wiki/Nausea" title="Nausea">nausea</a>, <a href="/wiki/Vomiting" title="Vomiting">vomiting</a>, and death of cells in the <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a> and <a href="/wiki/Gastrointestinal_tract" title="Gastrointestinal tract" class="mw-redirect">gastrointestinal tract</a>, and increased effectiveness against tumor cells.</p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Traditional_lung_cancer_classification_and_treatment"><span class="tocnumber">1</span> <span class="toctext">Traditional lung cancer classification and treatment</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Targeted_lung_cancer_agents_in_current_use"><span class="tocnumber">2</span> <span class="toctext">Targeted lung cancer agents in current use</span></a></li>
<li class="toclevel-1 tocsection-3"><a href="#Non-small_cell_lung_cancer"><span class="tocnumber">3</span> <span class="toctext">Non-small cell lung cancer</span></a></li>
<li class="toclevel-1 tocsection-4"><a href="#Small-cell_lung_cancer"><span class="tocnumber">4</span> <span class="toctext">Small-cell lung cancer</span></a></li>
<li class="toclevel-1 tocsection-5"><a href="#Combined_small-cell_lung_cancer"><span class="tocnumber">5</span> <span class="toctext">Combined small-cell lung cancer</span></a></li>
<li class="toclevel-1 tocsection-6"><a href="#References"><span class="tocnumber">6</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#External_links"><span class="tocnumber">7</span> <span class="toctext">External links</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Traditional_lung_cancer_classification_and_treatment">Traditional lung cancer classification and treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;action=edit&amp;section=1" title="Edit section: Traditional lung cancer classification and treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote boilerplate seealso">See also: <a href="/wiki/Treatment_of_lung_cancer" title="Treatment of lung cancer">Treatment of lung cancer</a></div>
<p>Lung cancer is an extremely <a href="/wiki/Heterogeneous" title="Heterogeneous" class="mw-redirect">heterogeneous</a> family of malignant <a href="/wiki/Neoplasms" title="Neoplasms" class="mw-redirect">neoplasms</a>,<sup id="cite_ref-RoggliVollmer_1-0" class="reference"><a href="#cite_note-RoggliVollmer-1"><span>[</span>1<span>]</span></a></sup> with well over 50 different <a href="/wiki/Histological" title="Histological" class="mw-redirect">histological</a> variants recognized under the 4th revision of the <a href="/wiki/World_Health_Organization" title="World Health Organization">World Health Organization</a> (WHO) typing system, currently the most widely used lung cancer classification scheme.<sup id="cite_ref-WHO2004_2-0" class="reference"><a href="#cite_note-WHO2004-2"><span>[</span>2<span>]</span></a></sup> Because these variants have differing genetic, biological, and clinical properties, including response to treatment, correct classification of lung cancer cases are necessary to assure that lung cancer patients receive optimum management.<sup id="cite_ref-RossiMarchioni_3-0" class="reference"><a href="#cite_note-RossiMarchioni-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-Vincent_4-0" class="reference"><a href="#cite_note-Vincent-4"><span>[</span>4<span>]</span></a></sup></p>
<p>Approximately 98% of lung cancers are <a href="/wiki/Carcinoma" title="Carcinoma">carcinoma</a>, a term describing malignancies derived from transformed cells exhibiting characteristics of <a href="/wiki/Epithelium" title="Epithelium">epithelium</a>. About 2% of all lung cancers are non-carcinoma (mainly <a href="/wiki/Sarcoma" title="Sarcoma">sarcoma</a>, tumors of <a href="/wiki/Hematopoietic" title="Hematopoietic" class="mw-redirect">hematopoietic</a> origin, or <a href="/wiki/Germ_cell" title="Germ cell">germ cell</a> tumors.<sup id="cite_ref-TravisTravis_5-0" class="reference"><a href="#cite_note-TravisTravis-5"><span>[</span>5<span>]</span></a></sup> These forms of lung cancer are usually treated differently from carcinomas. Because of the ubiquity of lung carcinomas, however, the term "lung cancer" generally refers to carcinomas in everyday clinical practice.</p>
<p>Despite the large number of histological variants of lung carcinoma, oncologists have long tended to favor a dichotomous division into small cell and non-small cell forms, based on differences in clinical behavior and response to treatment. Most small cell lung carcinomas (SCLC's) metastasize to distant organs early on in their course, rendering surgery ineffective in curing the cancer. In contrast, non-small cell lung carcinomas (NSCLC's) are more likely to remain localized to the <a href="/wiki/Thorax" title="Thorax">thorax</a> during development, and are thus more amenable to cure using radical surgical resection. Additionally, SCLC's are typically much more sensitive to chemotherapy and/or radiation therapy than are NSCLC's. Therefore, current traditional treatment guidelines and standards of care recommend, when possible, the use of surgery for NSCLC, and chemotherapy with or without radiotherapy for SCLC.<sup id="cite_ref-SimonTurrisi_6-0" class="reference"><a href="#cite_note-SimonTurrisi-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-NSCLCGuidelines_7-0" class="reference"><a href="#cite_note-NSCLCGuidelines-7"><span>[</span>7<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Targeted_lung_cancer_agents_in_current_use">Targeted lung cancer agents in current use</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;action=edit&amp;section=2" title="Edit section: Targeted lung cancer agents in current use">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>While a very large number of <a href="/wiki/Molecularly_targeted_therapy" title="Molecularly targeted therapy" class="mw-redirect">agents targeting various molecular pathways</a> are being developed and tested, the main classes and agents that are now being used in lung cancer treatment include:<sup id="cite_ref-DempkeSuto_8-0" class="reference"><a href="#cite_note-DempkeSuto-8"><span>[</span>8<span>]</span></a></sup></p>
<ul>
<li>Inhibitors of <a href="/wiki/Epidermal_growth_factor_receptor" title="Epidermal growth factor receptor">Epidermal growth factor receptor</a> (EGFR)
<ul>
<li><a href="/wiki/Tyrosine_kinase_inhibitors" title="Tyrosine kinase inhibitors" class="mw-redirect">tyrosine kinase inhibitors</a> (TKI's):<sup id="cite_ref-AnsariPalmer_9-0" class="reference"><a href="#cite_note-AnsariPalmer-9"><span>[</span>9<span>]</span></a></sup>
<ul>
<li><a href="/wiki/Erlotinib" title="Erlotinib">erlotinib</a> (Tarceva)<sup id="cite_ref-Tarceva_10-0" class="reference"><a href="#cite_note-Tarceva-10"><span>[</span>10<span>]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (December 2012)">unreliable medical source?</span></a></i>]</sup></li>
<li><a href="/wiki/Gefitinib" title="Gefitinib">gefitinib</a> (Iressa)<sup id="cite_ref-Iressa_11-0" class="reference"><a href="#cite_note-Iressa-11"><span>[</span>11<span>]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (December 2012)">unreliable medical source?</span></a></i>]</sup></li>
</ul>
</li>
<li>monoclonal antibody against EGFR:
<ul>
<li><a href="/wiki/Cetuximab" title="Cetuximab">cetuximab</a> (Erbitux)<sup id="cite_ref-Erbitux_12-0" class="reference"><a href="#cite_note-Erbitux-12"><span>[</span>12<span>]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (December 2012)">unreliable medical source?</span></a></i>]</sup></li>
</ul>
</li>
</ul>
</li>
<li>Inhibitors of <a href="/wiki/Vascular_endothelial_growth_factor" title="Vascular endothelial growth factor">vascular endothelial growth factor</a> (VEGF)<sup id="cite_ref-YangWang2_13-0" class="reference"><a href="#cite_note-YangWang2-13"><span>[</span>13<span>]</span></a></sup>
<ul>
<li><a href="/wiki/Bevacizumab" title="Bevacizumab">bevacizumab</a> (Avastin)<sup id="cite_ref-Avastin_14-0" class="reference"><a href="#cite_note-Avastin-14"><span>[</span>14<span>]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (December 2012)">unreliable medical source?</span></a></i>]</sup></li>
</ul>
</li>
<li>Inhibitor of <a href="/wiki/EML4-ALK_positive_lung_cancer" title="EML4-ALK positive lung cancer">EML4-ALK</a>
<ul>
<li><a href="/wiki/Crizotinib" title="Crizotinib">crizotinib</a> shows benefit in a subset of non-small cell lung cancer that is characterized by the <a href="/wiki/EML4-ALK_positive_lung_cancer" title="EML4-ALK positive lung cancer">EML4-ALK</a> fusion <a href="/wiki/Oncogene" title="Oncogene">oncogene</a>,<sup id="cite_ref-HemOncToday20100605_15-0" class="reference"><a href="#cite_note-HemOncToday20100605-15"><span>[</span>15<span>]</span></a></sup><sup id="cite_ref-16" class="reference"><a href="#cite_note-16"><span>[</span>16<span>]</span></a></sup> found in some relatively young, never or light smokers with adenocarcinoma.<sup id="cite_ref-pmid20418096_17-0" class="reference"><a href="#cite_note-pmid20418096-17"><span>[</span>17<span>]</span></a></sup></li>
</ul>
</li>
</ul>
<h2><span class="mw-headline" id="Non-small_cell_lung_cancer">Non-small cell lung cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;action=edit&amp;section=3" title="Edit section: Non-small cell lung cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Targeted agents are beginning to permit the design of more rational treatment regimens for <a href="/wiki/Non-small_cell_lung_cancer" title="Non-small cell lung cancer" class="mw-redirect">non-small cell lung cancer</a> (NSCLC), which comprises about 80% to 85% of all lung cancers.<sup id="cite_ref-RossiMarchioni_3-1" class="reference"><a href="#cite_note-RossiMarchioni-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-Vincent_4-1" class="reference"><a href="#cite_note-Vincent-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-SpiroTanner_18-0" class="reference"><a href="#cite_note-SpiroTanner-18"><span>[</span>18<span>]</span></a></sup></p>
<p>While there have been no randomized clinical trials of targeted agents in combined small-cell lung carcinoma (c-SCLC),<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (December 2012)">citation needed</span></a></i>]</sup> some small case series suggest that some may be useful in c-SCLC. Many targeted agents appear more active in certain NSCLC variants. Given that c-SCLC contains components of NSCLC, and that the chemoradioresistance of NSCLC components impact the effectiveness of c-SCLC treatment, these agents may permit the design of more rational treatment regimens for c-SCLC.<sup id="cite_ref-RossiMarchioni_3-2" class="reference"><a href="#cite_note-RossiMarchioni-3"><span>[</span>3<span>]</span></a></sup><sup id="cite_ref-Vincent_4-2" class="reference"><a href="#cite_note-Vincent-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-SpiroTanner_18-1" class="reference"><a href="#cite_note-SpiroTanner-18"><span>[</span>18<span>]</span></a></sup></p>
<p>EGFR-TKI's have been found to be active against variants exhibiting certain mutations in the EGFR <a href="/wiki/Gene" title="Gene">gene</a>.<sup id="cite_ref-StahelRA1_19-0" class="reference"><a href="#cite_note-StahelRA1-19"><span>[</span>19<span>]</span></a></sup><sup id="cite_ref-JiLi_20-0" class="reference"><a href="#cite_note-JiLi-20"><span>[</span>20<span>]</span></a></sup><sup id="cite_ref-ShigematsuGazdar_21-0" class="reference"><a href="#cite_note-ShigematsuGazdar-21"><span>[</span>21<span>]</span></a></sup><sup id="cite_ref-RielyPoliti_22-0" class="reference"><a href="#cite_note-RielyPoliti-22"><span>[</span>22<span>]</span></a></sup> While EGFR mutations are very rare (&lt;5%) in "pure" SCLC, they are considerably more common (about 15%-20%) in c-SCLC,<sup id="cite_ref-TatematsuShimizu_23-0" class="reference"><a href="#cite_note-TatematsuShimizu-23"><span>[</span>23<span>]</span></a></sup><sup id="cite_ref-FukuiTsuta_24-0" class="reference"><a href="#cite_note-FukuiTsuta-24"><span>[</span>24<span>]</span></a></sup> particularly in non-smoking females whose c-SCLC tumors contain an adenocarcinoma component. These patients are much more likely to have classical EGFR mutations in the small cell component of their tumors as well, and their tumors seem to be more likely to respond to treatment with EGFR-TKI's.<sup id="cite_ref-FukuiTsuta_24-1" class="reference"><a href="#cite_note-FukuiTsuta-24"><span>[</span>24<span>]</span></a></sup><sup id="cite_ref-ZakowskiLadanya_25-0" class="reference"><a href="#cite_note-ZakowskiLadanya-25"><span>[</span>25<span>]</span></a></sup><sup id="cite_ref-OkamotoAraki_26-0" class="reference"><a href="#cite_note-OkamotoAraki-26"><span>[</span>26<span>]</span></a></sup> EGFR-targeted agents appear particularly effective in <a href="/wiki/Papillary_adenocarcinoma" title="Papillary adenocarcinoma">papillary adenocarcinoma</a>,<sup id="cite_ref-DeOliveira_27-0" class="reference"><a href="#cite_note-DeOliveira-27"><span>[</span>27<span>]</span></a></sup><sup id="cite_ref-MotoiSzoke_28-0" class="reference"><a href="#cite_note-MotoiSzoke-28"><span>[</span>28<span>]</span></a></sup> non-mucinous <a href="/wiki/Bronchioloalveolar_carcinoma" title="Bronchioloalveolar carcinoma" class="mw-redirect">bronchioloalveolar carcinoma</a>,<sup id="cite_ref-ZakowskiHussain_29-0" class="reference"><a href="#cite_note-ZakowskiHussain-29"><span>[</span>29<span>]</span></a></sup> and <a href="/w/index.php?title=Adenocarcinoma_with_mixed_subtypes&amp;action=edit&amp;redlink=1" class="new" title="Adenocarcinoma with mixed subtypes (page does not exist)">adenocarcinoma with mixed subtypes</a>.<sup id="cite_ref-MotoiSzoke_28-1" class="reference"><a href="#cite_note-MotoiSzoke-28"><span>[</span>28<span>]</span></a></sup></p>
<p><a href="/wiki/Bevacizumab" title="Bevacizumab">Bevacizumab</a> may improve some measures of survival in both SCLC<sup id="cite_ref-HornDahlberg_30-0" class="reference"><a href="#cite_note-HornDahlberg-30"><span>[</span>30<span>]</span></a></sup> and non-squamous cell variants of NSCLC.<sup id="cite_ref-Vincent_4-3" class="reference"><a href="#cite_note-Vincent-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-SpiroTanner_18-2" class="reference"><a href="#cite_note-SpiroTanner-18"><span>[</span>18<span>]</span></a></sup><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Identifying_reliable_sources_(medicine)" title="Wikipedia:Identifying reliable sources (medicine)"><span title="Material near this tag may use an unreliable or less reliable medical source. (December 2012)">unreliable medical source?</span></a></i>]</sup></p>
<p><a href="/wiki/Pemetrexed" title="Pemetrexed">Pemetrexed</a>, although not classified as a targeted agent, has been shown to have improve survival in non-squamous cell NSCLC, and is the first drug to reveal differential survival benefit in large cell lung carcinoma.<sup id="cite_ref-Vincent_4-4" class="reference"><a href="#cite_note-Vincent-4"><span>[</span>4<span>]</span></a></sup><sup id="cite_ref-ZinnerNovello_31-0" class="reference"><a href="#cite_note-ZinnerNovello-31"><span>[</span>31<span>]</span></a></sup></p>
<p>Interestingly, c-SCLC appear to express female hormone (i.e. estrogen and/or progesterone) receptors in a high (50%-67%) proportion of cases, similar to breast carcinomas<sup id="cite_ref-SicaWagner_32-0" class="reference"><a href="#cite_note-SicaWagner-32"><span>[</span>32<span>]</span></a></sup> However, it is at present unknown whether blockade of these receptors affects the growth of c-SCLC.</p>
<p>Several studies have shown that EGFR-TKI's are particularly active in papillary and non-mucinous bronchioloalveolar carcinoma variants of adenocarcinoma.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (December 2010)">citation needed</span></a></i>]</sup></p>
<p>Bevacizumab is <a href="/wiki/Contraindicated" title="Contraindicated" class="mw-redirect">contraindicated</a> in squamous cell carcinoma and its variants.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (December 2010)">citation needed</span></a></i>]</sup></p>
<p>Pemetrexed has been approved for treating non-squamous lung carcinomas, and is the first drug that has been specifically shown to improve survival in <a href="/wiki/Large_cell_carcinoma" title="Large cell carcinoma" class="mw-redirect">large cell carcinoma</a>.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (December 2010)">citation needed</span></a></i>]</sup></p>
<h2><span class="mw-headline" id="Small-cell_lung_cancer">Small-cell lung cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;action=edit&amp;section=4" title="Edit section: Small-cell lung cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>To date, most clinical trials of newer targeted agents - both alone and in combination with previously tested treatment regimens - have either been less effective, or no more effective, than older platinum-based doublets in SCLC.<sup id="cite_ref-RossiMaione_33-0" class="reference"><a href="#cite_note-RossiMaione-33"><span>[</span>33<span>]</span></a></sup><sup id="cite_ref-RossiGaletta_34-0" class="reference"><a href="#cite_note-RossiGaletta-34"><span>[</span>34<span>]</span></a></sup><sup id="cite_ref-JalalAnsari_35-0" class="reference"><a href="#cite_note-JalalAnsari-35"><span>[</span>35<span>]</span></a></sup><sup id="cite_ref-CheeJett_36-0" class="reference"><a href="#cite_note-CheeJett-36"><span>[</span>36<span>]</span></a></sup><sup id="cite_ref-SocinskiSmit_37-0" class="reference"><a href="#cite_note-SocinskiSmit-37"><span>[</span>37<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Combined_small-cell_lung_cancer">Combined small-cell lung cancer</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;action=edit&amp;section=5" title="Edit section: Combined small-cell lung cancer">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote boilerplate seealso">See also: <a href="/wiki/Combined_small-cell_lung_carcinoma" title="Combined small-cell lung carcinoma">Combined small-cell lung carcinoma</a></div>
<p>The term "combined small-cell lung carcinoma" (c-SCLC) refers to a multiphasic lung cancer that contains a component of SCLC admixed with one (or more) components of NSCLC. It is currently considered a variant of SCLC under the current World Health Organization lung tumor classification scheme.<sup id="cite_ref-WHO2004_2-1" class="reference"><a href="#cite_note-WHO2004-2"><span>[</span>2<span>]</span></a></sup> While the true incidence of c-SCLC is unknown, case series suggest that they may account for as many as 25% to 30% of all cases of SCLC, and for 4% to 6% of all lung cancer cases.<sup id="cite_ref-NicholsonBeasley_38-0" class="reference"><a href="#cite_note-NicholsonBeasley-38"><span>[</span>38<span>]</span></a></sup><sup id="cite_ref-ACSFAF2009_39-0" class="reference"><a href="#cite_note-ACSFAF2009-39"><span>[</span>39<span>]</span></a></sup></p>
<p>Traditionally, c-SCLC have been treated according to guidelines established for "pure" SCLC.<sup id="cite_ref-SimonTurrisi_6-1" class="reference"><a href="#cite_note-SimonTurrisi-6"><span>[</span>6<span>]</span></a></sup><sup id="cite_ref-NCCNSCLC_40-0" class="reference"><a href="#cite_note-NCCNSCLC-40"><span>[</span>40<span>]</span></a></sup></p>
<p>To date, most clinical trials of targeted agents, alone and in combination with previously tested treatment regimens, have either been ineffective in SCLC or no more effective than standard platinum-based doublets.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (December 2010)">citation needed</span></a></i>]</sup></p>
<p>While there have been no randomized clinical trials of targeted agents in c-SCLC, some small case series suggest that some agents currently in use may be beneficial in c-SCLC. Many targeted agents appear more active in certain NSCLC variants. Given that c-SCLC contains components of NSCLC, and that the chemoradioresistance of NSCLC components impact the effectiveness of c-SCLC treatment, these agents may permit the design of more rational treatment regimens for c-SCLC.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (December 2010)">citation needed</span></a></i>]</sup></p>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;action=edit&amp;section=6" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-RoggliVollmer-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-RoggliVollmer_1-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Roggli VL, Vollmer RT, Greenberg SD, McGavran MH, Spjut HJ, Yesner R (June 1985). "Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases". <i><a href="/wiki/Human_Pathology" title="Human Pathology">Human Pathology</a></i> <b>16</b> (6): 569–79. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2FS0046-8177%2885%2980106-4">10.1016/S0046-8177(85)80106-4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2987102">2987102</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Lung+cancer+heterogeneity%3A+a+blinded+and+randomized+study+of+100+consecutive+cases&amp;rft.aulast=Roggli+VL%2C+Vollmer+RT%2C+Greenberg+SD%2C+McGavran+MH%2C+Spjut+HJ%2C+Yesner+R&amp;rft.au=Roggli+VL%2C+Vollmer+RT%2C+Greenberg+SD%2C+McGavran+MH%2C+Spjut+HJ%2C+Yesner+R&amp;rft.date=June+1985&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0046-8177%2885%2980106-4&amp;rft_id=info%3Apmid%2F2987102&amp;rft.issue=6&amp;rft.jtitle=Human+Pathology&amp;rft.pages=569-79&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-WHO2004-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-WHO2004_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-WHO2004_2-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (Eds.): World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press: Lyon 2004.</span></li>
<li id="cite_note-RossiMarchioni-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-RossiMarchioni_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RossiMarchioni_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-RossiMarchioni_3-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text">Rossi G, Marchioni A, Sartori1 G, Longo L, Piccinini S, Cavazza A. <a rel="nofollow" class="external text" href="http://biblioteca.asmn.re.it/pubblicazioni/Current%20Respiratory%20Medicine%20Reviews%202007.pdf">Histotype in non-small cell lung cancer therapy and staging: The emerging role of an old and underrated factor.</a> Curr Resp Med Rev 2007; 3: 69-77.</span></li>
<li id="cite_note-Vincent-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-Vincent_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Vincent_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Vincent_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Vincent_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Vincent_4-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Vincent MD (August 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2722061">"Optimizing the management of advanced non-small-cell lung cancer: a personal view"</a>. <i><a href="/w/index.php?title=Current_Oncology&amp;action=edit&amp;redlink=1" class="new" title="Current Oncology (page does not exist)">Current Oncology</a></i> <b>16</b> (4): 9–21. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.3747%2Fco.v16i4.465">10.3747/co.v16i4.465</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2722061">2722061</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19672420">19672420</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Optimizing+the+management+of+advanced+non-small-cell+lung+cancer%3A+a+personal+view&amp;rft.aulast=Vincent+MD&amp;rft.au=Vincent+MD&amp;rft.date=August+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2722061&amp;rft_id=info%3Adoi%2F10.3747%2Fco.v16i4.465&amp;rft_id=info%3Apmc%2F2722061&amp;rft_id=info%3Apmid%2F19672420&amp;rft.issue=4&amp;rft.jtitle=Current+Oncology&amp;rft.pages=9-21&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=16" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-TravisTravis-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-TravisTravis_5-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Travis WD, Travis LB, Devesa SS (January 1995). "Lung cancer". <i><a href="/wiki/Cancer" title="Cancer">Cancer</a></i> <b>75</b> (1 Suppl): 191–202. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2F1097-0142%2819950101%2975%3A1%2B%3C191%3A%3AAID-CNCR2820751307%3E3.0.CO%3B2-Y">10.1002/1097-0142(19950101)75:1+&lt;191::AID-CNCR2820751307&gt;3.0.CO;2-Y</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/8000996">8000996</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Lung+cancer&amp;rft.aulast=Travis+WD%2C+Travis+LB%2C+Devesa+SS&amp;rft.au=Travis+WD%2C+Travis+LB%2C+Devesa+SS&amp;rft.date=January+1995&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F1097-0142%2819950101%2975%3A1%2B%3C191%3A%3AAID-CNCR2820751307%3E3.0.CO%3B2-Y&amp;rft_id=info%3Apmid%2F8000996&amp;rft.issue=1+Suppl&amp;rft.jtitle=Cancer&amp;rft.pages=191-202&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=75" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SimonTurrisi-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-SimonTurrisi_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-SimonTurrisi_6-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Simon GR, Turrisi A (September 2007). "Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)". <i><a href="/wiki/Chest_(journal)" title="Chest (journal)">Chest</a></i> <b>132</b> (3 Suppl): 324S–339S. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1378%2Fchest.07-1385">10.1378/chest.07-1385</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17873178">17873178</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Management+of+small+cell+lung+cancer%3A+ACCP+evidence-based+clinical+practice+guidelines+%282nd+edition%29&amp;rft.aulast=Simon+GR%2C+Turrisi+A&amp;rft.au=Simon+GR%2C+Turrisi+A&amp;rft.date=September+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1378%2Fchest.07-1385&amp;rft_id=info%3Apmid%2F17873178&amp;rft.issue=3+Suppl&amp;rft.jtitle=Chest&amp;rft.pages=324S-339S&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=132" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NSCLCGuidelines-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-NSCLCGuidelines_7-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, Somerfield MR, Brouwers MC, Darling G, Ellis PM, Gaspar LE, Pass HI, Spigel DR, Strawn JR, Ung YC, Shepherd FA (December 2007). "Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline". <i><a href="/wiki/Journal_of_Clinical_Oncology" title="Journal of Clinical Oncology">Journal of Clinical Oncology</a></i> <b>25</b> (34): 5506–18. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1200%2FJCO.2007.14.1226">10.1200/JCO.2007.14.1226</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17954710">17954710</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Cancer+Care+Ontario+and+American+Society+of+Clinical+Oncology+adjuvant+chemotherapy+and+adjuvant+radiation+therapy+for+stages+I-IIIA+resectable+non+small-cell+lung+cancer+guideline&amp;rft.aulast=Pisters+KM%2C+Evans+WK%2C+Azzoli+CG%2C+Kris+MG%2C+Smith+CA%2C+Desch+CE%2C+Somerfield+MR%2C+Brouwers+MC%2C+Darling+G%2C+Ellis+PM%2C+Gaspar+LE%2C+Pass+HI%2C+Spigel+DR%2C+Strawn+JR%2C+Ung+YC%2C+Shepherd+FA&amp;rft.au=Pisters+KM%2C+Evans+WK%2C+Azzoli+CG%2C+Kris+MG%2C+Smith+CA%2C+Desch+CE%2C+Somerfield+MR%2C+Brouwers+MC%2C+Darling+G%2C+Ellis+PM%2C+Gaspar+LE%2C+Pass+HI%2C+Spigel+DR%2C+Strawn+JR%2C+Ung+YC%2C+Shepherd+FA&amp;rft.date=December+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2007.14.1226&amp;rft_id=info%3Apmid%2F17954710&amp;rft.issue=34&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.pages=5506-18&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=25" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-DempkeSuto-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-DempkeSuto_8-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Dempke WC, Suto T, Reck M (March 2010). "Targeted therapies for non-small cell lung cancer". <i><a href="/w/index.php?title=Lung_Cancer_(Amsterdam,_Netherlands)&amp;action=edit&amp;redlink=1" class="new" title="Lung Cancer (Amsterdam, Netherlands) (page does not exist)">Lung Cancer (Amsterdam, Netherlands)</a></i> <b>67</b> (3): 257–74. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.lungcan.2009.10.012">10.1016/j.lungcan.2009.10.012</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19914732">19914732</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Targeted+therapies+for+non-small+cell+lung+cancer&amp;rft.au=Dempke+WC%2C+Suto+T%2C+Reck+M&amp;rft.aulast=Dempke+WC%2C+Suto+T%2C+Reck+M&amp;rft.date=March+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.lungcan.2009.10.012&amp;rft_id=info%3Apmid%2F19914732&amp;rft.issue=3&amp;rft.jtitle=Lung+Cancer+%28Amsterdam%2C+Netherlands%29&amp;rft.pages=257-74&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=67" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-AnsariPalmer-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-AnsariPalmer_9-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ansari J, Palmer DH, Rea DW, Hussain SA (June 2009). "Role of tyrosine kinase inhibitors in lung cancer". <i><a href="/w/index.php?title=Anti-cancer_Agents_in_Medicinal_Chemistry&amp;action=edit&amp;redlink=1" class="new" title="Anti-cancer Agents in Medicinal Chemistry (page does not exist)">Anti-cancer Agents in Medicinal Chemistry</a></i> <b>9</b> (5): 569–75. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19519298">19519298</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Role+of+tyrosine+kinase+inhibitors+in+lung+cancer&amp;rft.au=Ansari+J%2C+Palmer+DH%2C+Rea+DW%2C+Hussain+SA&amp;rft.aulast=Ansari+J%2C+Palmer+DH%2C+Rea+DW%2C+Hussain+SA&amp;rft.date=June+2009&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F19519298&amp;rft.issue=5&amp;rft.jtitle=Anti-cancer+Agents+in+Medicinal+Chemistry&amp;rft.pages=569-75&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Tarceva-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-Tarceva_10-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.tarceva.com">http://www.tarceva.com</a></span></li>
<li id="cite_note-Iressa-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-Iressa_11-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.iressa.com">http://www.iressa.com</a></span></li>
<li id="cite_note-Erbitux-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-Erbitux_12-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.erbitux.com">http://www.erbitux.com</a></span></li>
<li id="cite_note-YangWang2-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-YangWang2_13-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Yang K, Wang YJ, Chen XR, Chen HN (2010). "Effectiveness and safety of bevacizumab for unresectable non-small-cell lung cancer: a meta-analysis". <i><a href="/w/index.php?title=Clinical_Drug_Investigation&amp;action=edit&amp;redlink=1" class="new" title="Clinical Drug Investigation (page does not exist)">Clinical Drug Investigation</a></i> <b>30</b> (4): 229–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.2165%2F11532260-000000000-00000">10.2165/11532260-000000000-00000</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20225906">20225906</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Effectiveness+and+safety+of+bevacizumab+for+unresectable+non-small-cell+lung+cancer%3A+a+meta-analysis&amp;rft.aulast=Yang+K%2C+Wang+YJ%2C+Chen+XR%2C+Chen+HN&amp;rft.au=Yang+K%2C+Wang+YJ%2C+Chen+XR%2C+Chen+HN&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.2165%2F11532260-000000000-00000&amp;rft_id=info%3Apmid%2F20225906&amp;rft.issue=4&amp;rft.jtitle=Clinical+Drug+Investigation&amp;rft.pages=229-41&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Avastin-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-Avastin_14-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="http://www.avastin.com/avastin/patient/index.m">http://www.avastin.com/avastin/patient/index.m</a></span></li>
<li id="cite_note-HemOncToday20100605-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-HemOncToday20100605_15-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.hemonctoday.com/article.aspx?rid=65251">"ALK inhibitor crizotinib has high response rate in patients with ALK-positive NSCLC"</a>. HemOncToday. 2010-06-05<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-06-07</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.btitle=ALK+inhibitor+crizotinib+has+high+response+rate+in+patients+with+ALK-positive+NSCLC&amp;rft.date=2010-06-05&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.hemonctoday.com%2Farticle.aspx%3Frid%3D65251&amp;rft.pub=HemOncToday&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><span class="citation web">Richard Pazdur&gt;publisher=FDA's Division of Oncology Drug Products. <a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/druginfo/fda-crizotinib">"FDA Approval for Crizotinib"</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.aulast=Richard+Pazdur%3Epublisher%3DFDA%27s+Division+of+Oncology+Drug+Products&amp;rft.au=Richard+Pazdur%3Epublisher%3DFDA%27s+Division+of+Oncology+Drug+Products&amp;rft.btitle=FDA+Approval+for+Crizotinib&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fcancertopics%2Fdruginfo%2Ffda-crizotinib&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid20418096-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid20418096_17-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Sasaki T, Rodig SJ, Chirieac LR, Jänne PA (July 2010). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2888755">"The biology and treatment of EML4-ALK non-small cell lung cancer"</a>. <i>Eur. J. Cancer</i> <b>46</b> (10): 1773–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.ejca.2010.04.002">10.1016/j.ejca.2010.04.002</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2888755">2888755</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20418096">20418096</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=The+biology+and+treatment+of+EML4-ALK+non-small+cell+lung+cancer&amp;rft.aulast=Sasaki+T%2C+Rodig+SJ%2C+Chirieac+LR%2C+J%C3%A4nne+PA&amp;rft.au=Sasaki+T%2C+Rodig+SJ%2C+Chirieac+LR%2C+J%C3%A4nne+PA&amp;rft.date=July+2010&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2888755&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ejca.2010.04.002&amp;rft_id=info%3Apmc%2F2888755&amp;rft_id=info%3Apmid%2F20418096&amp;rft.issue=10&amp;rft.jtitle=Eur.+J.+Cancer&amp;rft.pages=1773-80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=46" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SpiroTanner-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-SpiroTanner_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-SpiroTanner_18-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-SpiroTanner_18-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Spiro SG, Tanner NT, Silvestri GA, Janes SM, Lim E, Vansteenkiste JF, Pirker R (January 2010). "Lung cancer: progress in diagnosis, staging and therapy". <i><a href="/w/index.php?title=Respirology_(Carlton,_Vic.)&amp;action=edit&amp;redlink=1" class="new" title="Respirology (Carlton, Vic.) (page does not exist)">Respirology (Carlton, Vic.)</a></i> <b>15</b> (1): 44–50. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1440-1843.2009.01674.x">10.1111/j.1440-1843.2009.01674.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20199634">20199634</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Lung+cancer%3A+progress+in+diagnosis%2C+staging+and+therapy&amp;rft.aulast=Spiro+SG%2C+Tanner+NT%2C+Silvestri+GA%2C+Janes+SM%2C+Lim+E%2C+Vansteenkiste+JF%2C+Pirker+R&amp;rft.au=Spiro+SG%2C+Tanner+NT%2C+Silvestri+GA%2C+Janes+SM%2C+Lim+E%2C+Vansteenkiste+JF%2C+Pirker+R&amp;rft.date=January+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1440-1843.2009.01674.x&amp;rft_id=info%3Apmid%2F20199634&amp;rft.issue=1&amp;rft.jtitle=Respirology+%28Carlton%2C+Vic.%29&amp;rft.pages=44-50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=15" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-StahelRA1-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-StahelRA1_19-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Stahel RA (July 2007). "Adenocarcinoma, a molecular perspective". <i><a href="/wiki/Annals_of_Oncology" title="Annals of Oncology">Annals of Oncology</a></i> <b>18</b> (Suppl 9): ix147–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Fannonc%2Fmdm310">10.1093/annonc/mdm310</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17631568">17631568</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Adenocarcinoma%2C+a+molecular+perspective&amp;rft.aulast=Stahel+RA&amp;rft.au=Stahel+RA&amp;rft.date=July+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdm310&amp;rft_id=info%3Apmid%2F17631568&amp;rft.issue=Suppl+9&amp;rft.jtitle=Annals+of+Oncology&amp;rft.pages=ix147-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=18" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-JiLi-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-JiLi_20-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Ji H, Li D, Chen L, Shimamura T, Kobayashi S, McNamara K, Mahmood U, Mitchell A, Sun Y, Al-Hashem R, Chirieac LR, Padera R, Bronson RT, Kim W, Jänne PA, Shapiro GI, Tenen D, Johnson BE, Weissleder R, Sharpless NE, Wong KK (June 2006). "The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies". <i><a href="/wiki/Cancer_Cell" title="Cancer Cell" class="mw-redirect">Cancer Cell</a></i> <b>9</b> (6): 485–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1016%2Fj.ccr.2006.04.022">10.1016/j.ccr.2006.04.022</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16730237">16730237</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=The+impact+of+human+EGFR+kinase+domain+mutations+on+lung+tumorigenesis+and+in+vivo+sensitivity+to+EGFR-targeted+therapies&amp;rft.au=Ji+H%2C+Li+D%2C+Chen+L%2C+Shimamura+T%2C+Kobayashi+S%2C+McNamara+K%2C+Mahmood+U%2C+Mitchell+A%2C+Sun+Y%2C+Al-Hashem+R%2C+Chirieac+LR%2C+Padera+R%2C+Bronson+RT%2C+Kim+W%2C+J%C3%A4nne+PA%2C+Shapiro+GI%2C+Tenen+D%2C+Johnson+BE%2C+Weissleder+R%2C+Sharpless+NE%2C+Wong+KK&amp;rft.aulast=Ji+H%2C+Li+D%2C+Chen+L%2C+Shimamura+T%2C+Kobayashi+S%2C+McNamara+K%2C+Mahmood+U%2C+Mitchell+A%2C+Sun+Y%2C+Al-Hashem+R%2C+Chirieac+LR%2C+Padera+R%2C+Bronson+RT%2C+Kim+W%2C+J%C3%A4nne+PA%2C+Shapiro+GI%2C+Tenen+D%2C+Johnson+BE%2C+Weissleder+R%2C+Sharpless+NE%2C+Wong+KK&amp;rft.date=June+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccr.2006.04.022&amp;rft_id=info%3Apmid%2F16730237&amp;rft.issue=6&amp;rft.jtitle=Cancer+Cell&amp;rft.pages=485-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ShigematsuGazdar-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-ShigematsuGazdar_21-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Shigematsu H, Gazdar AF (January 2006). "Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers". <i><a href="/w/index.php?title=International_Journal_of_Cancer._Journal_International_Du_Cancer&amp;action=edit&amp;redlink=1" class="new" title="International Journal of Cancer. Journal International Du Cancer (page does not exist)">International Journal of Cancer. Journal International Du Cancer</a></i> <b>118</b> (2): 257–62. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fijc.21496">10.1002/ijc.21496</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16231326">16231326</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Somatic+mutations+of+epidermal+growth+factor+receptor+signaling+pathway+in+lung+cancers&amp;rft.aulast=Shigematsu+H%2C+Gazdar+AF&amp;rft.au=Shigematsu+H%2C+Gazdar+AF&amp;rft.date=January+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.21496&amp;rft_id=info%3Apmid%2F16231326&amp;rft.issue=2&amp;rft.jtitle=International+Journal+of+Cancer.+Journal+International+Du+Cancer&amp;rft.pages=257-62&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=118" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-RielyPoliti-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-RielyPoliti_22-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Riely GJ, Politi KA, Miller VA, Pao W (December 2006). "Update on epidermal growth factor receptor mutations in non-small cell lung cancer". <i><a href="/wiki/Clinical_Cancer_Research_:_an_Official_Journal_of_the_American_Association_for_Cancer_Research" title="Clinical Cancer Research : an Official Journal of the American Association for Cancer Research" class="mw-redirect">Clinical Cancer Research : an Official Journal of the American Association for Cancer Research</a></i> <b>12</b> (24): 7232–41. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1158%2F1078-0432.CCR-06-0658">10.1158/1078-0432.CCR-06-0658</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17189394">17189394</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Update+on+epidermal+growth+factor+receptor+mutations+in+non-small+cell+lung+cancer&amp;rft.aulast=Riely+GJ%2C+Politi+KA%2C+Miller+VA%2C+Pao+W&amp;rft.au=Riely+GJ%2C+Politi+KA%2C+Miller+VA%2C+Pao+W&amp;rft.date=December+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-06-0658&amp;rft_id=info%3Apmid%2F17189394&amp;rft.issue=24&amp;rft.jtitle=Clinical+Cancer+Research+%3A+an+Official+Journal+of+the+American+Association+for+Cancer+Research&amp;rft.pages=7232-41&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=12" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-TatematsuShimizu-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-TatematsuShimizu_23-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Tatematsu A, Shimizu J, Murakami Y, Horio Y, Nakamura S, Hida T, Mitsudomi T, Yatabe Y (October 2008). "Epidermal growth factor receptor mutations in small cell lung cancer". <i><a href="/wiki/Clinical_Cancer_Research_:_an_Official_Journal_of_the_American_Association_for_Cancer_Research" title="Clinical Cancer Research : an Official Journal of the American Association for Cancer Research" class="mw-redirect">Clinical Cancer Research : an Official Journal of the American Association for Cancer Research</a></i> <b>14</b> (19): 6092–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1158%2F1078-0432.CCR-08-0332">10.1158/1078-0432.CCR-08-0332</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18829487">18829487</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Epidermal+growth+factor+receptor+mutations+in+small+cell+lung+cancer&amp;rft.aulast=Tatematsu+A%2C+Shimizu+J%2C+Murakami+Y%2C+Horio+Y%2C+Nakamura+S%2C+Hida+T%2C+Mitsudomi+T%2C+Yatabe+Y&amp;rft.au=Tatematsu+A%2C+Shimizu+J%2C+Murakami+Y%2C+Horio+Y%2C+Nakamura+S%2C+Hida+T%2C+Mitsudomi+T%2C+Yatabe+Y&amp;rft.date=October+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1158%2F1078-0432.CCR-08-0332&amp;rft_id=info%3Apmid%2F18829487&amp;rft.issue=19&amp;rft.jtitle=Clinical+Cancer+Research+%3A+an+Official+Journal+of+the+American+Association+for+Cancer+Research&amp;rft.pages=6092-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=14" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-FukuiTsuta-24"><span class="mw-cite-backlink">^ <a href="#cite_ref-FukuiTsuta_24-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-FukuiTsuta_24-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Fukui T, Tsuta K, Furuta K, Watanabe S, Asamura H, Ohe Y, Maeshima AM, Shibata T, Masuda N, Matsuno Y (November 2007). "Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung". <i><a href="/wiki/Cancer_Science" title="Cancer Science">Cancer Science</a></i> <b>98</b> (11): 1714–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1111%2Fj.1349-7006.2007.00600.x">10.1111/j.1349-7006.2007.00600.x</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17784875">17784875</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Epidermal+growth+factor+receptor+mutation+status+and+clinicopathological+features+of+combined+small+cell+carcinoma+with+adenocarcinoma+of+the+lung&amp;rft.au=Fukui+T%2C+Tsuta+K%2C+Furuta+K%2C+Watanabe+S%2C+Asamura+H%2C+Ohe+Y%2C+Maeshima+AM%2C+Shibata+T%2C+Masuda+N%2C+Matsuno+Y&amp;rft.aulast=Fukui+T%2C+Tsuta+K%2C+Furuta+K%2C+Watanabe+S%2C+Asamura+H%2C+Ohe+Y%2C+Maeshima+AM%2C+Shibata+T%2C+Masuda+N%2C+Matsuno+Y&amp;rft.date=November+2007&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1349-7006.2007.00600.x&amp;rft_id=info%3Apmid%2F17784875&amp;rft.issue=11&amp;rft.jtitle=Cancer+Science&amp;rft.pages=1714-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=98" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ZakowskiLadanya-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-ZakowskiLadanya_25-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Zakowski MF, Ladanyi M, Kris MG (July 2006). "EGFR mutations in small-cell lung cancers in patients who have never smoked". <i><a href="/wiki/The_New_England_Journal_of_Medicine" title="The New England Journal of Medicine">The New England Journal of Medicine</a></i> <b>355</b> (2): 213–5. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1056%2FNEJMc053610">10.1056/NEJMc053610</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16837691">16837691</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=EGFR+mutations+in+small-cell+lung+cancers+in+patients+who+have+never+smoked&amp;rft.aulast=Zakowski+MF%2C+Ladanyi+M%2C+Kris+MG&amp;rft.au=Zakowski+MF%2C+Ladanyi+M%2C+Kris+MG&amp;rft.date=July+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMc053610&amp;rft_id=info%3Apmid%2F16837691&amp;rft.issue=2&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.pages=213-5&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=355" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-OkamotoAraki-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-OkamotoAraki_26-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Okamoto I, Araki J, Suto R, Shimada M, Nakagawa K, Fukuoka M (June 2006). "EGFR mutation in gefitinib-responsive small-cell lung cancer". <i><a href="/wiki/Annals_of_Oncology" title="Annals of Oncology">Annals of Oncology</a></i> <b>17</b> (6): 1028–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1093%2Fannonc%2Fmdj114">10.1093/annonc/mdj114</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16357019">16357019</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=EGFR+mutation+in+gefitinib-responsive+small-cell+lung+cancer&amp;rft.aulast=Okamoto+I%2C+Araki+J%2C+Suto+R%2C+Shimada+M%2C+Nakagawa+K%2C+Fukuoka+M&amp;rft.au=Okamoto+I%2C+Araki+J%2C+Suto+R%2C+Shimada+M%2C+Nakagawa+K%2C+Fukuoka+M&amp;rft.date=June+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdj114&amp;rft_id=info%3Apmid%2F16357019&amp;rft.issue=6&amp;rft.jtitle=Annals+of+Oncology&amp;rft.pages=1028-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=17" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-DeOliveira-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-DeOliveira_27-0">^</a></b></span> <span class="reference-text"><span class="citation journal">De Oliveira Duarte Achcar R, Nikiforova MN, Yousem SA (May 2009). "Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile". <i><a href="/w/index.php?title=American_Journal_of_Clinical_Pathology&amp;action=edit&amp;redlink=1" class="new" title="American Journal of Clinical Pathology (page does not exist)">American Journal of Clinical Pathology</a></i> <b>131</b> (5): 694–700. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1309%2FAJCPBS85VJEOBPDO">10.1309/AJCPBS85VJEOBPDO</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19369630">19369630</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Micropapillary+lung+adenocarcinoma%3A+EGFR%2C+K-ras%2C+and+BRAF+mutational+profile&amp;rft.au=De+Oliveira+Duarte+Achcar+R%2C+Nikiforova+MN%2C+Yousem+SA&amp;rft.aulast=De+Oliveira+Duarte+Achcar+R%2C+Nikiforova+MN%2C+Yousem+SA&amp;rft.date=May+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1309%2FAJCPBS85VJEOBPDO&amp;rft_id=info%3Apmid%2F19369630&amp;rft.issue=5&amp;rft.jtitle=American+Journal+of+Clinical+Pathology&amp;rft.pages=694-700&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=131" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-MotoiSzoke-28"><span class="mw-cite-backlink">^ <a href="#cite_ref-MotoiSzoke_28-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MotoiSzoke_28-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Motoi N, Szoke J, Riely GJ, Seshan VE, Kris MG, Rusch VW, Gerald WL, Travis WD (June 2008). "Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis". <i><a href="/wiki/The_American_Journal_of_Surgical_Pathology" title="The American Journal of Surgical Pathology">The American Journal of Surgical Pathology</a></i> <b>32</b> (6): 810–27. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2FPAS.0b013e31815cb162">10.1097/PAS.0b013e31815cb162</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18391747">18391747</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Lung+adenocarcinoma%3A+modification+of+the+2004+WHO+mixed+subtype+to+include+the+major+histologic+subtype+suggests+correlations+between+papillary+and+micropapillary+adenocarcinoma+subtypes%2C+EGFR+mutations+and+gene+expression+analysis&amp;rft.aulast=Motoi+N%2C+Szoke+J%2C+Riely+GJ%2C+Seshan+VE%2C+Kris+MG%2C+Rusch+VW%2C+Gerald+WL%2C+Travis+WD&amp;rft.au=Motoi+N%2C+Szoke+J%2C+Riely+GJ%2C+Seshan+VE%2C+Kris+MG%2C+Rusch+VW%2C+Gerald+WL%2C+Travis+WD&amp;rft.date=June+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FPAS.0b013e31815cb162&amp;rft_id=info%3Apmid%2F18391747&amp;rft.issue=6&amp;rft.jtitle=The+American+Journal+of+Surgical+Pathology&amp;rft.pages=810-27&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ZakowskiHussain-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-ZakowskiHussain_29-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Zakowski MF, Hussain S, Pao W, Ladanyi M, Ginsberg MS, Heelan R, Miller VA, Rusch VW, Kris MG (March 2009). "Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib". <i><a href="/wiki/Archives_of_Pathology_%26_Laboratory_Medicine" title="Archives of Pathology &amp; Laboratory Medicine">Archives of Pathology &amp; Laboratory Medicine</a></i> <b>133</b> (3): 470–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1043%2F1543-2165-133.3.470">10.1043/1543-2165-133.3.470</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19260752">19260752</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Morphologic+features+of+adenocarcinoma+of+the+lung+predictive+of+response+to+the+epidermal+growth+factor+receptor+kinase+inhibitors+erlotinib+and+gefitinib&amp;rft.aulast=Zakowski+MF%2C+Hussain+S%2C+Pao+W%2C+Ladanyi+M%2C+Ginsberg+MS%2C+Heelan+R%2C+Miller+VA%2C+Rusch+VW%2C+Kris+MG&amp;rft.au=Zakowski+MF%2C+Hussain+S%2C+Pao+W%2C+Ladanyi+M%2C+Ginsberg+MS%2C+Heelan+R%2C+Miller+VA%2C+Rusch+VW%2C+Kris+MG&amp;rft.date=March+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1043%2F1543-2165-133.3.470&amp;rft_id=info%3Apmid%2F19260752&amp;rft.issue=3&amp;rft.jtitle=Archives+of+Pathology+%26+Laboratory+Medicine&amp;rft.pages=470-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=133" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-HornDahlberg-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-HornDahlberg_30-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Horn L, Dahlberg SE, Sandler AB, Dowlati A, Moore DF, Murren JR, Schiller JH (December 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2793043">"Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern Cooperative Oncology Group Study E3501"</a>. <i><a href="/wiki/Journal_of_Clinical_Oncology_:_Official_Journal_of_the_American_Society_of_Clinical_Oncology" title="Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology" class="mw-redirect">Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology</a></i> <b>27</b> (35): 6006–11. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1200%2FJCO.2009.23.7545">10.1200/JCO.2009.23.7545</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2793043">2793043</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19826110">19826110</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Phase+II+study+of+cisplatin+plus+etoposide+and+bevacizumab+for+previously+untreated%2C+extensive-stage+small-cell+lung+cancer%3A+Eastern+Cooperative+Oncology+Group+Study+E3501&amp;rft.au=Horn+L%2C+Dahlberg+SE%2C+Sandler+AB%2C+Dowlati+A%2C+Moore+DF%2C+Murren+JR%2C+Schiller+JH&amp;rft.aulast=Horn+L%2C+Dahlberg+SE%2C+Sandler+AB%2C+Dowlati+A%2C+Moore+DF%2C+Murren+JR%2C+Schiller+JH&amp;rft.date=December+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2793043&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2009.23.7545&amp;rft_id=info%3Apmc%2F2793043&amp;rft_id=info%3Apmid%2F19826110&amp;rft.issue=35&amp;rft.jtitle=Journal+of+Clinical+Oncology+%3A+Official+Journal+of+the+American+Society+of+Clinical+Oncology&amp;rft.pages=6006-11&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ZinnerNovello-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-ZinnerNovello_31-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Zinner RG, Novello S, Peng G, Herbst R, Obasaju C, Scagliotti G (March 2010). "Comparison of patient outcomes according to histology among pemetrexed-treated patients with stage IIIB/IV non-small-cell lung cancer in two phase II trials". <i><a href="/wiki/Clinical_Lung_Cancer" title="Clinical Lung Cancer">Clinical Lung Cancer</a></i> <b>11</b> (2): 126–31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.3816%2FCLC.2010.n.017">10.3816/CLC.2010.n.017</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20199979">20199979</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Comparison+of+patient+outcomes+according+to+histology+among+pemetrexed-treated+patients+with+stage+IIIB%2FIV+non-small-cell+lung+cancer+in+two+phase+II+trials&amp;rft.aulast=Zinner+RG%2C+Novello+S%2C+Peng+G%2C+Herbst+R%2C+Obasaju+C%2C+Scagliotti+G&amp;rft.au=Zinner+RG%2C+Novello+S%2C+Peng+G%2C+Herbst+R%2C+Obasaju+C%2C+Scagliotti+G&amp;rft.date=March+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3816%2FCLC.2010.n.017&amp;rft_id=info%3Apmid%2F20199979&amp;rft.issue=2&amp;rft.jtitle=Clinical+Lung+Cancer&amp;rft.pages=126-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=11" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SicaWagner-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-SicaWagner_32-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Sica G, Wagner PL, Altorki N, Port J, Lee PC, Vazquez MF, Saqi A (December 2008). "Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors". <i><a href="/wiki/Archives_of_Pathology_%26_Laboratory_Medicine" title="Archives of Pathology &amp; Laboratory Medicine">Archives of Pathology &amp; Laboratory Medicine</a></i> <b>132</b> (12): 1889–95. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1043%2F1543-2165-132.12.1889">10.1043/1543-2165-132.12.1889</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19061285">19061285</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Immunohistochemical+expression+of+estrogen+and+progesterone+receptors+in+primary+pulmonary+neuroendocrine+tumors&amp;rft.aulast=Sica+G%2C+Wagner+PL%2C+Altorki+N%2C+Port+J%2C+Lee+PC%2C+Vazquez+MF%2C+Saqi+A&amp;rft.au=Sica+G%2C+Wagner+PL%2C+Altorki+N%2C+Port+J%2C+Lee+PC%2C+Vazquez+MF%2C+Saqi+A&amp;rft.date=December+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1043%2F1543-2165-132.12.1889&amp;rft_id=info%3Apmid%2F19061285&amp;rft.issue=12&amp;rft.jtitle=Archives+of+Pathology+%26+Laboratory+Medicine&amp;rft.pages=1889-95&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=132" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-RossiMaione-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-RossiMaione_33-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rossi A, Maione P, Palazzolo G, Sacco PC, Ferrara ML, Falanga M, Gridelli C (September 2008). "New targeted therapies and small-cell lung cancer". <i><a href="/wiki/Clinical_Lung_Cancer" title="Clinical Lung Cancer">Clinical Lung Cancer</a></i> <b>9</b> (5): 271–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.3816%2FCLC.2008.n.042">10.3816/CLC.2008.n.042</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18824449">18824449</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=New+targeted+therapies+and+small-cell+lung+cancer&amp;rft.aulast=Rossi+A%2C+Maione+P%2C+Palazzolo+G%2C+Sacco+PC%2C+Ferrara+ML%2C+Falanga+M%2C+Gridelli+C&amp;rft.au=Rossi+A%2C+Maione+P%2C+Palazzolo+G%2C+Sacco+PC%2C+Ferrara+ML%2C+Falanga+M%2C+Gridelli+C&amp;rft.date=September+2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3816%2FCLC.2008.n.042&amp;rft_id=info%3Apmid%2F18824449&amp;rft.issue=5&amp;rft.jtitle=Clinical+Lung+Cancer&amp;rft.pages=271-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=9" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-RossiGaletta-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-RossiGaletta_34-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Rossi A, Galetta D, Gridelli C (2009). "Biological prognostic and predictive factors in lung cancer". <i><a href="/w/index.php?title=Oncology_(journal)&amp;action=edit&amp;redlink=1" class="new" title="Oncology (journal) (page does not exist)">Oncology</a></i>. 77 Suppl 1: 90–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1159%2F000258500">10.1159/000258500</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20130436">20130436</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Biological+prognostic+and+predictive+factors+in+lung+cancer&amp;rft.aulast=Rossi+A%2C+Galetta+D%2C+Gridelli+C&amp;rft.au=Rossi+A%2C+Galetta+D%2C+Gridelli+C&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1159%2F000258500&amp;rft_id=info%3Apmid%2F20130436&amp;rft.jtitle=Oncology&amp;rft.pages=90-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=77+Suppl+1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-JalalAnsari-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-JalalAnsari_35-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Jalal S, Ansari R, Govindan R, Bhatia S, Bruetman D, Fisher W, Masters G, White A, Stover D, Yu M, Hanna N (January 2009). "Pemetrexed in second line and beyond small cell lung cancer: a Hoosier Oncology Group phase II study". <i><a href="/w/index.php?title=Journal_of_Thoracic_Oncology&amp;action=edit&amp;redlink=1" class="new" title="Journal of Thoracic Oncology (page does not exist)">Journal of Thoracic Oncology</a></i> <b>4</b> (1): 93–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2FJTO.0b013e31818de1e6">10.1097/JTO.0b013e31818de1e6</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19096313">19096313</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Pemetrexed+in+second+line+and+beyond+small+cell+lung+cancer%3A+a+Hoosier+Oncology+Group+phase+II+study&amp;rft.au=Jalal+S%2C+Ansari+R%2C+Govindan+R%2C+Bhatia+S%2C+Bruetman+D%2C+Fisher+W%2C+Masters+G%2C+White+A%2C+Stover+D%2C+Yu+M%2C+Hanna+N&amp;rft.aulast=Jalal+S%2C+Ansari+R%2C+Govindan+R%2C+Bhatia+S%2C+Bruetman+D%2C+Fisher+W%2C+Masters+G%2C+White+A%2C+Stover+D%2C+Yu+M%2C+Hanna+N&amp;rft.date=January+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2FJTO.0b013e31818de1e6&amp;rft_id=info%3Apmid%2F19096313&amp;rft.issue=1&amp;rft.jtitle=Journal+of+Thoracic+Oncology&amp;rft.pages=93-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=4" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-CheeJett-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-CheeJett_36-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Chee CE, Jett JR, Bernath AM, Foster NR, Nelson GD, Molina J, Nikcevich DA, Steen PD, Flynn PJ, Rowland KM (May 2010). "Phase 2 trial of pemetrexed disodium and carboplatin in previously untreated extensive-stage small cell lung cancer, N0423". <i><a href="/wiki/Cancer" title="Cancer">Cancer</a></i> <b>116</b> (10): 2382–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1002%2Fcncr.24967">10.1002/cncr.24967</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20209614">20209614</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Phase+2+trial+of+pemetrexed+disodium+and+carboplatin+in+previously+untreated+extensive-stage+small+cell+lung+cancer%2C+N0423&amp;rft.au=Chee+CE%2C+Jett+JR%2C+Bernath+AM%2C+Foster+NR%2C+Nelson+GD%2C+Molina+J%2C+Nikcevich+DA%2C+Steen+PD%2C+Flynn+PJ%2C+Rowland+KM&amp;rft.aulast=Chee+CE%2C+Jett+JR%2C+Bernath+AM%2C+Foster+NR%2C+Nelson+GD%2C+Molina+J%2C+Nikcevich+DA%2C+Steen+PD%2C+Flynn+PJ%2C+Rowland+KM&amp;rft.date=May+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.24967&amp;rft_id=info%3Apmid%2F20209614&amp;rft.issue=10&amp;rft.jtitle=Cancer&amp;rft.pages=2382-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=116" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-SocinskiSmit-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-SocinskiSmit_37-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Socinski MA, Smit EF, Lorigan P, Konduri K, Reck M, Szczesna A, Blakely J, Serwatowski P, Karaseva NA, Ciuleanu T, Jassem J, Dediu M, Hong S, Visseren-Grul C, Hanauske AR, Obasaju CK, Guba SC, Thatcher N (October 2009). "Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer". <i><a href="/wiki/Journal_of_Clinical_Oncology" title="Journal of Clinical Oncology">Journal of Clinical Oncology</a></i> <b>27</b> (28): 4787–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1200%2FJCO.2009.23.1548">10.1200/JCO.2009.23.1548</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19720897">19720897</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Phase+III+study+of+pemetrexed+plus+carboplatin+compared+with+etoposide+plus+carboplatin+in+chemotherapy-naive+patients+with+extensive-stage+small-cell+lung+cancer&amp;rft.aulast=Socinski+MA%2C+Smit+EF%2C+Lorigan+P%2C+Konduri+K%2C+Reck+M%2C+Szczesna+A%2C+Blakely+J%2C+Serwatowski+P%2C+Karaseva+NA%2C+Ciuleanu+T%2C+Jassem+J%2C+Dediu+M%2C+Hong+S%2C+Visseren-Grul+C%2C+Hanauske+AR%2C+Obasaju+CK%2C+Guba+SC%2C+Thatcher+N&amp;rft.au=Socinski+MA%2C+Smit+EF%2C+Lorigan+P%2C+Konduri+K%2C+Reck+M%2C+Szczesna+A%2C+Blakely+J%2C+Serwatowski+P%2C+Karaseva+NA%2C+Ciuleanu+T%2C+Jassem+J%2C+Dediu+M%2C+Hong+S%2C+Visseren-Grul+C%2C+Hanauske+AR%2C+Obasaju+CK%2C+Guba+SC%2C+Thatcher+N&amp;rft.date=October+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1200%2FJCO.2009.23.1548&amp;rft_id=info%3Apmid%2F19720897&amp;rft.issue=28&amp;rft.jtitle=Journal+of+Clinical+Oncology&amp;rft.pages=4787-92&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=27" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NicholsonBeasley-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-NicholsonBeasley_38-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Nicholson SA, Beasley MB, Brambilla E, Hasleton PS, Colby TV, Sheppard MN, Falk R, Travis WD (September 2002). "Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens". <i><a href="/wiki/The_American_Journal_of_Surgical_Pathology" title="The American Journal of Surgical Pathology">The American Journal of Surgical Pathology</a></i> <b>26</b> (9): 1184–97. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="http://dx.doi.org/10.1097%2F00000478-200209000-00009">10.1097/00000478-200209000-00009</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12218575">12218575</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.atitle=Small+cell+lung+carcinoma+%28SCLC%29%3A+a+clinicopathologic+study+of+100+cases+with+surgical+specimens&amp;rft.aulast=Nicholson+SA%2C+Beasley+MB%2C+Brambilla+E%2C+Hasleton+PS%2C+Colby+TV%2C+Sheppard+MN%2C+Falk+R%2C+Travis+WD&amp;rft.au=Nicholson+SA%2C+Beasley+MB%2C+Brambilla+E%2C+Hasleton+PS%2C+Colby+TV%2C+Sheppard+MN%2C+Falk+R%2C+Travis+WD&amp;rft.date=September+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1097%2F00000478-200209000-00009&amp;rft_id=info%3Apmid%2F12218575&amp;rft.issue=9&amp;rft.jtitle=The+American+Journal+of+Surgical+Pathology&amp;rft.pages=1184-97&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=26" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ACSFAF2009-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-ACSFAF2009_39-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.cancer.org/Research/CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2009">"Cancer Facts &amp; Figures 2009"</a>. American Cancer Society.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.btitle=Cancer+Facts+%26+Figures+2009&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cancer.org%2FResearch%2FCancerFactsFigures%2FCancerFactsFigures%2Fcancer-facts-figures-2009&amp;rft.pub=American+Cancer+Society&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NCCNSCLC-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-NCCNSCLC_40-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.nccn.org/professionals/physician_gls/PDF/sclc.pdf">"NCCN Clinical Practice Guidelines in Oncology: Small Cell Lung Cancer"</a> (PDF). National Comprehensive Cancer Network. V.1.2010.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATargeted+therapy+of+lung+cancer&amp;rft.btitle=NCCN+Clinical+Practice+Guidelines+in+Oncology%3A+Small+Cell+Lung+Cancer&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2FPDF%2Fsclc.pdf&amp;rft.pub=National+Comprehensive+Cancer+Network&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;action=edit&amp;section=7" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul>
<li><a rel="nofollow" class="external text" href="http://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb10/BB10.pdf/">World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart.</a></li>
<li><a rel="nofollow" class="external text" href="http://www.cancer.gov/cancertopics/types/lung">Lung Cancer page</a> at the National Cancer Institute.</li>
</ul>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2" style="background:Silver">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Respiratory_neoplasia" title="Template:Respiratory neoplasia"><span title="View this template" style=";background:Silver;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Respiratory_neoplasia" title="Template talk:Respiratory neoplasia"><span title="Discuss this template" style=";background:Silver;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Respiratory_neoplasia&amp;action=edit"><span title="Edit this template" style=";background:Silver;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Tumor" title="Tumor" class="mw-redirect">Tumors</a>: <a href="/wiki/Mediastinal_tumor" title="Mediastinal tumor">Mediastinal tumors</a>/<a href="/wiki/Thoracic_neoplasm" title="Thoracic neoplasm" class="mw-redirect">Thoracic neoplasm</a>/<a href="/wiki/Respiratory_tract_neoplasm" title="Respiratory tract neoplasm">respiratory neoplasia</a> (<a href="/wiki/ICD-10_Chapter_II:_Neoplasms#.28C30.E2.80.93C39.29_Malignant_neoplasms.2C_respiratory_system_and_intrathoracic_organs" title="ICD-10 Chapter II: Neoplasms">C30–C34/D14</a>, <a href="/wiki/List_of_ICD-9_codes_140%E2%80%93239:_neoplasms#Malignant_neoplasm_of_respiratory_and_intrathoracic_organs_.28160.E2.80.93165.29" title="List of ICD-9 codes 140–239: neoplasms">160–163/212.0–212.4</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:MistyRose;"><a href="/wiki/Upper_respiratory_tract" title="Upper respiratory tract" class="mw-redirect">Upper RT</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<dl>
<dt><i><a href="/wiki/Nasal_cavity" title="Nasal cavity">Nasal cavity</a></i></dt>
<dd><a href="/wiki/Esthesioneuroblastoma" title="Esthesioneuroblastoma">Esthesioneuroblastoma</a></dd>
</dl>
<dl>
<dt><i><a href="/wiki/Nasopharynx" title="Nasopharynx" class="mw-redirect">Nasopharynx</a></i></dt>
<dd><a href="/wiki/Nasopharyngeal_carcinoma" title="Nasopharyngeal carcinoma" class="mw-redirect">Nasopharyngeal carcinoma</a></dd>
<dd><a href="/wiki/Nasopharyngeal_angiofibroma" title="Nasopharyngeal angiofibroma">Nasopharyngeal angiofibroma</a></dd>
</dl>
<dl>
<dt><i><a href="/wiki/Larynx" title="Larynx">Larynx</a></i></dt>
<dd><a href="/wiki/Laryngeal_cancer" title="Laryngeal cancer">Laryngeal cancer</a></dd>
<dd><a href="/wiki/Laryngeal_papillomatosis" title="Laryngeal papillomatosis">Laryngeal papillomatosis</a></dd>
</dl>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:MistyRose;"><a href="/wiki/Lower_respiratory_tract" title="Lower respiratory tract" class="mw-redirect">Lower RT</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Vertebrate_trachea" title="Vertebrate trachea" class="mw-redirect">Trachea</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Tracheal_tumor" title="Tracheal tumor">Tracheal tumor</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Lung_cancer" title="Lung cancer">Lung</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Non-small-cell_lung_carcinoma" title="Non-small-cell lung carcinoma">Non-small-cell lung carcinoma</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Squamous_cell_lung_carcinoma#Squamous_cell_lung_carcinoma" title="Squamous cell lung carcinoma" class="mw-redirect">Squamous cell carcinoma</a></li>
<li><a href="/wiki/Adenocarcinoma_of_the_lung" title="Adenocarcinoma of the lung">Adenocarcinoma of the lung</a> (<a href="/wiki/Mucinous_cystadenocarcinoma_of_the_lung" title="Mucinous cystadenocarcinoma of the lung">Mucinous cystadenocarcinoma</a>)</li>
<li><a href="/wiki/Large-cell_lung_carcinoma" title="Large-cell lung carcinoma">Large-cell lung carcinoma</a></li>
<li><a href="/wiki/Large-cell_lung_carcinoma_with_rhabdoid_phenotype" title="Large-cell lung carcinoma with rhabdoid phenotype">Rhabdoid carcinoma</a></li>
<li><a href="/wiki/Sarcomatoid_carcinoma" title="Sarcomatoid carcinoma">Sarcomatoid carcinoma</a></li>
<li><a href="/wiki/Typical_pulmonary_carcinoid_tumour" title="Typical pulmonary carcinoid tumour">Carcinoid</a></li>
<li><a href="/wiki/Salivary_gland-like_carcinoma_of_the_lung" title="Salivary gland-like carcinoma of the lung" class="mw-redirect">Salivary gland-like carcinoma of the lung</a></li>
<li><a href="/wiki/Adenosquamous_carcinoma" title="Adenosquamous carcinoma">Adenosquamous carcinoma</a></li>
<li><a href="/wiki/Papillary_adenocarcinoma" title="Papillary adenocarcinoma">Papillary adenocarcinoma</a></li>
<li><a href="/wiki/Giant-cell_carcinoma_of_the_lung" title="Giant-cell carcinoma of the lung">Giant cell carcinoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Small-cell_carcinoma" title="Small-cell carcinoma">Small-cell carcinoma</a></div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Combined_small-cell_lung_carcinoma" title="Combined small-cell lung carcinoma">Combined small-cell carcinoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:MistyRose;">
<div style="padding:0em 0.75em;">Non-<a href="/wiki/Carcinoma" title="Carcinoma">carcinoma</a></div>
</th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Sarcoma" title="Sarcoma">Sarcoma</a></li>
<li><a href="/wiki/Lymphoma" title="Lymphoma">Lymphoma</a></li>
<li><a href="/wiki/Immature_teratoma" title="Immature teratoma">Immature teratoma</a></li>
<li><a href="/wiki/Melanoma" title="Melanoma">Melanoma</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="padding-left:0em;padding-right:0em;background:MistyRose;">
<div style="padding:0em 0.75em;">By location</div>
</th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Pancoast_tumor" title="Pancoast tumor">Pancoast tumor</a></li>
<li><a href="/wiki/Solitary_pulmonary_nodule" title="Solitary pulmonary nodule">Solitary pulmonary nodule</a></li>
<li><a href="/wiki/Hilum_of_lung" title="Hilum of lung" class="mw-redirect">Central lung</a></li>
<li><a href="/wiki/Bronchiole" title="Bronchiole">Peripheral lung</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group" style="background:MistyRose;"><a href="/wiki/Pleura" title="Pleura" class="mw-redirect">Pleura</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Mesothelioma" title="Mesothelioma">Mesothelioma</a></li>
<li><a href="/wiki/Malignant" title="Malignant" class="mw-redirect">Malignant</a> <a href="/wiki/Solitary_fibrous_tumor" title="Solitary fibrous tumor">solitary fibrous tumor</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<td class="navbox-abovebelow" colspan="2">
<div>
<div style="text-align:center; position:relative; white-space:nowrap;"><b>Index of the <a href="/wiki/Respiratory_system" title="Respiratory system">respiratory system</a></b>
<div class="plainlinks hlist navbar mini" style="position:absolute; right:0; top:0; margin:0 5px;">
<ul>
<li class="nv-view"><a href="/wiki/Template:Respiratory_system_navs" title="Template:Respiratory system navs"><span title="View this template" style="">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Respiratory_system_navs" title="Template talk:Respiratory system navs"><span title="Discuss this template" style="">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Respiratory_system_navs&amp;action=edit"><span title="Edit this template" style="">e</span></a></li>
</ul>
</div>
</div>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Anatomy
<ul>
<li><a href="/wiki/Template:Nose_anatomy" title="Template:Nose anatomy">nose</a></li>
<li><a href="/wiki/Template:Larynx_anatomy" title="Template:Larynx anatomy">larynx</a></li>
<li><a href="/wiki/Template:Lower_respiratory_system_anatomy" title="Template:Lower respiratory system anatomy">lower</a></li>
<li><a href="/wiki/Template:Thoracic_cavity" title="Template:Thoracic cavity">thorax</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Respiratory_physiology" title="Template:Respiratory physiology">Physiology</a></li>
<li><a href="/wiki/Template:Development_of_respiratory_system" title="Template:Development of respiratory system">Development</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disease</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Congenital_malformations_and_deformations_of_respiratory_system" title="Template:Congenital malformations and deformations of respiratory system">Congenital</a></li>
<li><a href="/wiki/Template:Respiratory_neoplasia" title="Template:Respiratory neoplasia">Neoplasms and cancer</a></li>
<li><a href="/wiki/Template:Chest_trauma" title="Template:Chest trauma">Chest trauma</a></li>
<li>Infection
<ul>
<li><a href="/wiki/Template:Common_cold" title="Template:Common cold">Common cold</a></li>
<li><a href="/wiki/Template:Pneumonia" title="Template:Pneumonia">Pneumonia</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Respiratory_pathology" title="Template:Respiratory pathology">Other</a></li>
<li><a href="/wiki/Template:Respiratory_system_symptoms_and_signs" title="Template:Respiratory system symptoms and signs">Symptoms and signs</a>
<ul>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_respiratory_system" title="Template:Eponymous medical signs for respiratory system">eponymous</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Respiratory_system_procedures" title="Template:Respiratory system procedures">Procedures</a></li>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Nasal_preparations" title="Template:Nasal preparations">nasal</a></li>
<li><a href="/wiki/Template:Throat_preparations" title="Template:Throat preparations">throat</a></li>
<li><a href="/wiki/Template:Drugs_for_obstructive_airway_diseases" title="Template:Drugs for obstructive airway diseases">obstructive airway diseases</a></li>
<li><a href="/wiki/Template:Cough_and_cold_preparations" title="Template:Cough and cold preparations">cough and cold</a></li>
<li><a href="/wiki/Template:Histaminergics" title="Template:Histaminergics">histaminergics</a></li>
<li><a href="/wiki/Template:Other_respiratory_system_products" title="Template:Other respiratory system products">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1002
CPU time usage: 1.684 seconds
Real time usage: 1.777 seconds
Preprocessor visited node count: 4307/1000000
Preprocessor generated node count: 13165/1500000
Post‐expand include size: 157423/2097152 bytes
Template argument size: 9922/2097152 bytes
Highest expansion depth: 15/40
Expensive parser function count: 5/500
Lua time usage: 0.249/10.000 seconds
Lua memory usage: 3.33 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00% 1448.546      1 - -total
 33.95%  491.744      1 - Template:Reflist
 24.14%  349.650      4 - Template:Navbox
 18.51%  268.132     11 - Template:Fix
 13.83%  200.405     30 - Template:Cite_journal
 13.68%  198.217      1 - Template:Respiratory_neoplasia
 13.52%  195.864     17 - Template:Category_handler
 11.41%  165.245      5 - Template:MEDRS
  8.87%  128.485      5 - Template:Citation_needed
  7.93%  114.855      2 - Template:Navbox_subgroup
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:26670758-0!*!0!!en!*!* and timestamp 20141230193659 and revision id 610049923
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>									<div class="printfooter">
						Retrieved from "<a dir="ltr" href="http://en.wikipedia.org/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;oldid=610049923">http://en.wikipedia.org/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;oldid=610049923</a>"					</div>
													<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Lung_cancer" title="Category:Lung cancer">Lung cancer</a></li><li><a href="/wiki/Category:Cancer_treatments" title="Category:Cancer treatments">Cancer treatments</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:All_articles_lacking_reliable_references" title="Category:All articles lacking reliable references">All articles lacking reliable references</a></li><li><a href="/wiki/Category:Articles_lacking_reliable_references_from_December_2012" title="Category:Articles lacking reliable references from December 2012">Articles lacking reliable references from December 2012</a></li><li><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_December_2012" title="Category:Articles with unsourced statements from December 2012">Articles with unsourced statements from December 2012</a></li><li><a href="/wiki/Category:Articles_with_unsourced_statements_from_December_2010" title="Category:Articles with unsourced statements from December 2010">Articles with unsourced statements from December 2010</a></li><li><a href="/wiki/Category:Pages_that_use_a_Medicine_navs_subtemplate" title="Category:Pages that use a Medicine navs subtemplate">Pages that use a Medicine navs subtemplate</a></li></ul></div></div>												<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Targeted+therapy+of+lung+cancer&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Targeted+therapy+of+lung+cancer" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Targeted_therapy_of_lung_cancer"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Targeted_therapy_of_lung_cancer"  title="Discussion about the content page [t]" accesskey="t">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label"><span>Variants</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Targeted_therapy_of_lung_cancer" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;action=edit"  title="You can edit this page. Please use the preview button before saving [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
														<div id="simpleSearch">
															<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />								</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
													<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
													<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
													<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li>
													<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
													<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
													<li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li>
													<li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikimedia Shop</a></li>
											</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
													<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
													<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
													<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
													<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
													<li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>
											</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
													<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Targeted_therapy_of_lung_cancer" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
													<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Targeted_therapy_of_lung_cancer" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
													<li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li>
													<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li>
													<li id="t-permalink"><a href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;oldid=610049923" title="Permanent link to this revision of the page">Permanent link</a></li>
													<li id="t-info"><a href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;action=info" title="More information about this page">Page information</a></li>
													<li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q7685917" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li>
						<li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Targeted_therapy_of_lung_cancer&amp;id=610049923" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
													<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Targeted+therapy+of+lung+cancer">Create a book</a></li>
													<li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Targeted+therapy+of+lung+cancer&amp;oldid=610049923&amp;writer=rdf2latex">Download as PDF</a></li>
													<li id="t-print"><a href="/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>
											</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
													<li class="uls-p-lang-dummy"><a href="#"></a></li>
											</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a action="edit" href="//www.wikidata.org/wiki/Q7685917#sitelinks-wikipedia" text="Edit links" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 25 May 2014 at 09:24.<br /></li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Targeted_therapy_of_lung_cancer&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
															<a href="//wikimediafoundation.org/"><img src="//bits.wikimedia.org/images/wikimedia-button.png" srcset="//bits.wikimedia.org/images/wikimedia-button-1.5x.png 1.5x, //bits.wikimedia.org/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>
													</li>
											<li id="footer-poweredbyico">
															<a href="//www.mediawiki.org/"><img src="//bits.wikimedia.org/static-1.25wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" width="88" height="31" /></a>
													</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>/*<![CDATA[*/window.jQuery && jQuery.ready();/*]]>*/</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<script>if(window.mw){
mw.loader.load(["ext.cite","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//bits.wikimedia.org/en.wikipedia.org/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":71,"wgHostname":"mw1249"});
}</script>
	</body>
</html>
